155 results on '"Marzac C"'
Search Results
2. P1.23-07 Clinical Impact of Clonal Hematopoiesis in Patients with Advanced Non-small Cell Lung Cancer: Results of the CHIC Study
3. Detection of myeloid malignancies through cfDNA profiling in patients with advanced stage cancer
4. 109P Characteristics of clonal hematopoiesis-related mutations identified in liquid biopsies from patients with metastatic solid tumors
5. High prevalence of Clonal Hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
6. 888MO Emergence of clonal hematopoiesis after peptide receptor radionuclide therapy for neuroendocrine tumors
7. 508P High prevalence of clonal hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
8. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation
9. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
10. Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
11. Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study
12. Mutation du gène UBA1 dans l’artérite à cellules géantes
13. Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
14. 2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study
15. Vasculogenic mimicry of acute leukemic bone marrow stromal cells
16. Correlation between molecular and histopathological diagnoses of B cell lymphomas in bone marrow biopsy and aspirates
17. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
18. 22 (PB008) - Detection of myeloid malignancies through cfDNA profiling in patients with advanced stage cancer
19. SIOG2022-0098 - High prevalence of Clonal Hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
20. Mécanismes de résistance aux agents cytostatiques
21. SIOG2023-2-P-226 - Clonal Hematopoiesis of indeterminate potential in patients with advanced NSCLC treated with ICB.
22. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.
23. O079 : Calr somatic mutations in a prospective cohort of 308 patients with splanchnic vein thrombosis
24. Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia
25. Syndrome d’activation macrophagique réactionnel de l’adulte : étude multicentrique rétrospective de 162 cas
26. Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
27. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study
28. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: A report on 241 cases
29. Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC
30. Clonalité sur des pièces d’exérèse de lymphomes digestifs de la zone marginale du Malt : sensibilité et signification
31. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients
32. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study
33. Pseudoleucémie par falsification d’examens biologiques : genèse d’un syndrome de Münchausen
34. Des lésions bulleuses des doigts
35. Biopsie médullaire osseuse
36. Mécanismes de résistance aux agents cytostatiques
37. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
38. Cytostatic drug resistance mechanisms.
39. 803MO CAR T cells reside in the bone marrow and inhibits healthy hematopoiesis.
40. 169P Characteristics of clonal hematopoiesis (CH) in patients with non-small cell lung cancer (NSCLC): A retrospective analysis of plasma cell-free DNA (cfDNA) comprehensive genomic profiling.
41. Mutation in TET2 in myeloid cancers.
42. Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas.
43. The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program.
44. Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial.
45. Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
46. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution.
47. An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO-based treatment.
48. When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
49. Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.
50. Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.